China NMPA approves Harbour BioMed and Kelun-Biotech’s IND application for HBM7575/SKB575 to treat atopic dermatitis

Join Pharma | Login

	Editorial


	DEFINITION ON OTC DRUGS
	Wednesday, March 4, 2026
	A robust regulatory framework for over-the-counter (OTC) medicines has been long overdue in the country. It is almost nine years since the Union Health Ministry constituted a subcommittee on the issue.
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	China NMPA approves Harbour BioMed and Kelun-Biotech’s IND application for HBM7575/SKB575 to treat atopic dermatitis
17:00 [IST]	IDEAYA Biosciences begins patient dosing in phase 1 trial of IDE892, a potential best-in-class PRMT5 inhibitor for MTAP-deleted solid tumours
16:00 [IST]	Fujitsu and DT-Axis collaborate to advance digital health
15:30 [IST]	Merck engages Young Minds at IISc Open Day 2026 with Interactive Science Activities
15:00 [IST]	METI & TSE select Chugai for the “2026 KENKO Investment for Health” for the third consecutive year
14:00 [IST]	Galderma introduces Cetaphil AM/PM Antioxidant Serums, a new science-driven defense and recovery system for sensitive skin

more news >>

TOP NEWS


08:00 [IST]	CDSCO asks stakeholders to submit application for prior intimation in line with recent NDCT Rules amendment
08:00 [IST]	AP pharmacists oppose move to allow non-pharmacists to run Jan Aushadhi Kendras
08:00 [IST]	Biopharma Shakti & regulatory agility can power India’s rise as a global innovation hub: Suneela Thatte
08:00 [IST]	Maharashtra, Gujarat & Uttarakhand lead in action against misleading ads in Ayush sector
08:00 [IST]	AIPA asks govt to withdraw proposal to allow PACS to operate JAKs without pharmacists
08:00 [IST]	Backed by increased participation from states, NSQ reporting grows over two-fold in 2025

more news >>

YESTERDAY'S NEWS


18:00 [IST]	Aisa Pharma announces positive results from phase 2 RECONNOITER trial of cilnidipine in patients with systemic sclerosis-associated Raynaud's phenomenon
17:00 [IST]	NIHR funds new Tessa Jowell AHP Fellowships in brain tumour care
16:00 [IST]	Epilepsy Foundation of America partners with SeizeSense to expand seizure safety awareness nationwide
15:30 [IST]	UK govt plans to crackdown on illegal underage sunbed use to cut teen cancer risk
15:00 [IST]	Allarity closes $20 mn financing to accelerate the advance of stenoparib toward US FDA approval and commercialization
14:15 [IST]	MedhAnkura secures multi-innovation recognition at 16th Aegis Graham Bell Awards

more news >>

INTERVIEW


Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training
Lalit Kumar Goel, State Drug Controller (SDC) of Haryana

Past Interviews...

	What's New?

iguratimod 25 mg tablet nebivolol 5 mg +telmisartan 40 mg tab hydroxyzine 25 mg oint methyl salicylate 450 gm clindamycin 100 mg + clotrimazole 200 mg etc...

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers